AGI vs CX

The Advanced Deterministic Scorecard reveals a mixed financial profile: the Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong profitability metrics and robust earnings growth, elevated valuation multiples and inconsistent quarterly earnings surprises weigh on sustainability. The stock trades significantly above the Graham Number of $16.89 and near the intrinsic value of $38.94, suggesting limited margin of safety. Analysts maintain a strong_buy consensus, but technical trend and insider sentiment are weak, indicating caution despite favorable sector-relative fundamentals.

CX presents a complex profile with a Piotroski F-Score of 4/9, indicating stable but non-improving financial health. While the company shows strong top-line revenue growth (10.10% YoY) and an extremely attractive PEG ratio of 0.39, these are offset by a severe collapse in earnings growth (-66.40% YoY). Liquidity is a primary concern with a current ratio of 0.86 and a quick ratio of 0.55, suggesting potential short-term obligations pressure. Despite a bullish analyst consensus and strong 1-year price performance, the provided technical trend score of 10/100 suggests a bearish shift in momentum.